UAMY Stock Draws Traders As Defense Contract Progress Accelerates

United States Antimony Corporation stocks have been trading up by 11.23 percent after bullish coverage on strategic antimony supply prospects.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading UAMY

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Third-quarter deliveries of high-purity MIL-SPEC antimony ingots under a $245M U.S. Defense Logistics Agency contract are advancing, backed by new Bolivian feedstock and low-cost Stibnite Hill ore.
Expanded processing capacity at a new Montana facility and over 400,000 pounds of low-cost Stibnite Hill material are positioned to boost shipment volumes and margins.
Texas Capital started coverage on UAMY with a Buy rating and a $9.50 price target, citing its unique antimony smelter position in the U.S. and critical mineral onshoring tailwinds.
A new three-year contract secures CEO Gary C. Evans’ role, with structured pay, bonus potential, and defined severance tied to termination or change-of-control scenarios.
Ongoing Q3 progress under the Defense Logistics Agency deal reinforces UAMY’s status as the only producer of MIL-SPEC antimony ingots in the Western Hemisphere.

Live Update At 12:32:12 EDT: On Monday, October 19, 2026 United States Antimony Corporation stock [NYSE: UAMY] is trending up by 11.23%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

United States Antimony Corporation, ticker UAMY, is trading like a classic high-volatility story stock wrapped around hard fundamentals. Over the last few weeks, UAMY has pulled back from the mid-$4s to roughly $3.17, but the tape still shows active trading and tight intraday ranges. That tells traders the market is digesting gains, not necessarily abandoning the story.

On the daily chart, UAMY has faded from a recent high near $4.57 down toward the low $3s, but it’s holding above prior bases. Intraday, the 5‑minute data shows a controlled grind from around $3.02 at the open to about $3.17 by midday, with no wild wicks or panic flushes. That’s constructive action for anyone stalking a potential next leg.

More Breaking News

Fundamentally, UAMY is still loss-making. Margins are deeply negative, with EBIT margin around -65.7% and profit margin near -44.6%. Yet revenue has grown more than 60% over three years, and the balance sheet carries almost no debt, with a current ratio of 11.5 and strong cash. For traders, that mix screams “high risk, high reward”: poor historical profitability, but a real business with $39.3M in annual revenue, ample liquidity, and clear operating leverage if the Defense contract and new capacity translate into better margins.

Why Traders Are Watching UAMY Now

UAMY is on a lot of watchlists because the story just shifted from potential to execution. The company is in the middle of delivering high-purity antimony ingots under a $245M sole-source contract with the U.S. Defense Logistics Agency. For a small-cap like United States Antimony, that’s a make-or-break, multi-year revenue backbone.

Management says third-quarter deliveries are progressing, supported by new Bolivian antimony feedstock and low-cost material from its Stibnite Hill project in Montana. That’s not just a mining side note. For traders, cheaper ore plus reliable foreign supply means any uptick in volume can drop more cleanly to the bottom line. UAMY has struggled with margins; this is how that script can change.

The company has also expanded processing capacity at a new Montana facility and started working through more than 400,000 pounds of low-cost Stibnite Hill ore. That’s a sizable volume base for a niche metals player. As throughput rises, traders will be watching for evidence that unit costs fall and gross margin climbs from the current 17.4% to something that actually supports positive earnings.

Layer on the strategic angle: UAMY is the only producer of MIL-SPEC antimony ingots in the Western Hemisphere. In a world focused on critical minerals and defense supply security, that positioning matters. Texas Capital clearly agrees; it initiated coverage with a Buy rating and a $9.50 price target on 2026/10/07, highlighting UAMY’s unique U.S. smelter status and extensive North American mining claims. That kind of Street validation often brings in new trading volume and can drive short squeezes when the float is tightly watched.

Finally, governance stability is in play. UAMY extended CEO Gary C. Evans on a three-year contract with a $430,000 base salary, bonus potential, and up to 2x salary plus target bonus in certain termination or change-of-control events. Traders will read that two ways: continuity while the Defense deal scales, and a reminder that any future strategic deal carries real executive costs.

Conclusion

UAMY sits at the crossroads of a strong narrative and tough numbers, which is exactly where active traders live. The company’s revenue has grown quickly, but historical losses and ugly margins make this far from a safe, steady play. What changes the game is that $245M Defense Logistics Agency contract, the sole-source nature of the deal, and UAMY’s role as the only MIL-SPEC antimony ingot producer in the Western Hemisphere.

With Bolivian feedstock flowing, Stibnite Hill ore being processed, and Montana capacity expanding, UAMY now has hard catalysts traders can track quarter by quarter. The Texas Capital Buy rating and $9.50 target frame a possible upside roadmap that the chart may start to price in if operational progress keeps hitting the tape. At the same time, the new CEO contract locks leadership in through this growth phase, even as it raises questions about eventual change-of-control costs.

For traders on the Tim Sykes-style grind, this is a textbook research setup: real news, clear catalysts, and a volatile chart. As Tim Sykes likes to say, “The market rewards prepared traders, not hopeful gamblers.” And as Tim Bohen, lead trainer with StocksToTrade says, “There’s a pattern in everything; you just have to stick around long enough to see it.” UAMY demands exactly that – detailed homework, tight risk controls, and a plan to cut losses fast if the Defense-driven margin story fails to show up in the numbers. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!